These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11425163)

  • 1. Short report: documentation of iodine deficiency in Haitian schoolchildren: implication for lymphatic filariasis elimination in Haiti.
    Beach MJ; Streit TG; Houston R; May WA; Addiss DG; Lammie PJ
    Am J Trop Med Hyg; 2001; 64(1-2):56-7. PubMed ID: 11425163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis.
    Lammie P; Milner T; Houston R
    Bull World Health Organ; 2007 Jul; 85(7):545-9. PubMed ID: 17768503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A community-based trial for the control of lymphatic filariasis and iodine deficiency using salt fortified with diethylcarbamazine and iodine.
    Freeman AR; Lammie PJ; Houston R; LaPointe MD; Streit TG; Jooste PL; Brissau JM; Lafontant JG; Addiss DG
    Am J Trop Med Hyg; 2001 Dec; 65(6):865-71. PubMed ID: 11791989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes.
    Houston R
    Parasitology; 2000; 121 Suppl():S161-73. PubMed ID: 11386687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.
    Sabesan S; Krishnamoorthy K; Hoti SL; Subramanian S; Srividya A; Roy N; Jain T; Kumar A; Rahi M
    Indian J Med Res; 2022 Mar; 155(3&4):347-355. PubMed ID: 36124509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti.
    Lammie PJ; Eberhard ML; Addiss DG; Won KY; Beau de Rochars M; Direny AN; Milord MD; Lafontant JG; Streit TG
    Am J Trop Med Hyg; 2017 Oct; 97(4_Suppl):71-75. PubMed ID: 29064364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of lymphatic filariasis in India.
    Sabesan S; Ravi R; Das PK
    Lancet Infect Dis; 2005 Jan; 5(1):4-5. PubMed ID: 15620551
    [No Abstract]   [Full Text] [Related]  

  • 8. School-based health education campaign--a potential tool for social mobilization to promote the use of DEC-fortified salt towards elimination of lymphatic filariasis.
    Nandha B; Krishnamoorthy K
    Health Educ Res; 2007 Aug; 22(4):539-46. PubMed ID: 17035351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technical measures of filariasis elimination in Tengzhou City].
    Ma XW; Zhang XQ; Xu YL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(4):232-4. PubMed ID: 12568031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographic examination of Haitian children with lymphatic filariasis: a longitudinal assessment in the context of antifilarial drug treatment.
    Fox LM; Furness BW; Haser JK; Brissau JM; Louis-Charles J; Wilson SF; Addiss DG; Lammie PJ; Beach MJ
    Am J Trop Med Hyg; 2005 May; 72(5):642-8. PubMed ID: 15891143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of lymphatic filariasis.
    Michael E; Malecela-Lazaro MN; Kazura JW
    Lancet; 2006 Jul; 368(9533):362-3; author reply 363-4. PubMed ID: 16876654
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic performance and cost-effectiveness of using a DEC-salt social enterprise for eliminating the major neglected tropical disease, lymphatic filariasis.
    Sharma S; Smith ME; Reimer J; O'Brien DB; Brissau JM; Donahue MC; Carter CE; Michael E
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007094. PubMed ID: 31260444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of transmission of lymphatic filariasis in Egypt.
    Molyneux DH
    Lancet; 2006 Mar; 367(9515):966-8. PubMed ID: 16564345
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti.
    Mathieu E; Deming M; Lammie PJ; McLaughlin SI; Beach MJ; Deodat DJ; Addiss DG
    Trans R Soc Trop Med Hyg; 2003; 97(5):501-5. PubMed ID: 15307410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.
    McLaughlin SI; Radday J; Michel MC; Addiss DG; Beach MJ; Lammie PJ; Lammie J; Rheingans R; Lafontant J
    Am J Trop Med Hyg; 2003 May; 68(5):568-73. PubMed ID: 12812348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 May; 78(20):171-9. PubMed ID: 12808788
    [No Abstract]   [Full Text] [Related]  

  • 17. Towards elimination of lymphatic filariasis in India.
    Das PK; Ramaiah KD; Augustin DJ; Kumar A
    Trends Parasitol; 2001 Oct; 17(10):457-60. PubMed ID: 11587940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A great success in lymphatic filariasis control in China. National Technical Steering Group for Filariasis Control and Research, MOPH.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):81-5. PubMed ID: 7554168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of iodine deficiency in Mongolia in 1998-1999.
    Yamada C; Oyunchimeg D; Enkhtuya P; Erdenbat A; Buttumur A; Umenai T
    Asia Pac J Public Health; 2000; 12(2):79-84. PubMed ID: 11836923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic filariasis in kenya since 1910, and the prospects for its elimination: a review.
    Wamae CN; Mwandawiro C; Wambayi E; Njenga S; Kiliku F
    East Afr Med J; 2001 Nov; 78(11):595-603. PubMed ID: 12219966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.